We have developed this blog specifically to track the creation of the regulatory framework for the cannabis industry in Massachusetts and provide insight on legal issues of concern to potential operators.
Earlier this week our cannabis attorneys Austin Ownbey and Regina DeSantis were joined by special guest Darrell Carrington from Carrington & Associates, LLC for a webinar to discuss the Maryland Round 1 application process.
Key Takeaways:
…
The New York Cannabis Control Board (the “CCB”) has extended the window for adult-use cannabis license applications by two weeks. The announcement came during the CCB hearing on Tuesday, October 17th. The new deadline to apply for expedited final Retail…
Key Takeaways:
…
As readers of this blog are well aware, the uncertainty surrounding the legality and enforceability of Massachusetts’ “Community Impact Fees,” most recently addressed by An Act Relative to Equity in the Cannabis Industry (“the Act”), which took effect in November…
Key Takeaways:
…
On Friday, September 8, the Maryland Cannabis Administration (MCA) Office of Social Equity released additional information for its upcoming initial licensing round, including the social equity verification portal, application timeframe and deadlines, and the number of licenses available per county. The…
As will be discussed in greater detail by the Foley Hoag’s cannabis practice team on its webinar scheduled for September 13, 2023, the New York Cannabis Control Board (“CCB”) and Office of Cannabis Management (“OCM”) took substantial and meaningful…
On September 8, 2023, the Cannabis Control Commission (“CCC”) held a hearing to discuss its proposed regulations, which were published in the Massachusetts Register on August 16. The regulations, which we discussed in a previous post here, fundamentally change…
As previously discussed by Foley Hoag’s attorneys in its Cannabis practice, a rescheduling of cannabis from a Schedule I Controlled Substance to a Schedule III Controlled Substance will provide cannabis businesses with the ability to claim tax deductions and…
Will the United States Attorney General, via the U.S. Drug Enforcement Administration (“DEA”) follow the recent recommendation of the U.S. Department of Health and Human Services (“HHS”) to reschedule cannabis to Schedule III? The plain language in the United States…
